Why AGI Is Noise and Data Is the Signal in Healthcare Innovation with Laurent Bride
AI has become omnipresent in biotech, with companies promising to slash drug development costs by factors of ten and predict clinical trial outcomes with unprecedented accuracy. However, Laurent Bride, Chief Digital Officer at Revolution Medicines, has a refreshingly grounded take that cuts through the hype: the AI model is rarely the problem. The data foundation is.
In a recent conversation on the Signal to Noise Podcast with host Matt Skiba, Laurent shares hard-won insights from his journey through enterprise software, health tech, and now biotech. His perspective challenges the prevailing narrative that better models alone will revolutionize healthcare. Instead, he argues that organizations need to get serious about data infrastructure before they can unlock AI’s true potential.
The Data Foundation Comes First
When Laurent joined Revolution Medicines, conversations naturally gravitated toward AI capabilities and what models the company should deploy. But he quickly redirected the focus.
“What we need is really that strong data foundation. If you look at any innovative startup out there, they’re all based on the data they’ve been able to assemble to train and validate their models.”
Revolution Medicines sits on one of the most complete RAS-addicted cancer databases in the world, giving it a genuine advantage. The pharmaceutical giants and AI startups making waves aren’t winning because they have secret algorithms. They’re winning because they’ve done the unglamorous work of assembling, cleaning, and structuring vast datasets that others simply don’t have access to.
Building Hybrid Teams That Actually Work
Moving from traditional enterprise software into healthcare presented Laurent with a crucial challenge: building teams that bridge technology expertise with deep domain knowledge. The answer isn’t just hiring unicorns who understand both worlds, though finding them is ideal. Instead, it’s about deliberately pairing tech-native talent with regulatory and scientific experts.
“Creating that dynamic is key. Fresh perspectives from engineers who’ve built products at scale can inject new thinking into traditionally slow-moving organizations. But success requires humility and genuine curiosity about science.”
The secret is exposure. When technical talent sees videos of patients whose lives were saved by drugs their data infrastructure helped develop, the mission becomes visceral. The question shifts from ‘Am I doing tech for the sake of tech?’ to ‘Am I having an impact on something that actually matters?’
Mastering Trade-offs in Compliance-Heavy Environments
Healthcare innovation operates under constraints that would paralyze many tech leaders. Between HIPAA compliance, GxP validation requirements, and the very real possibility that a data breach could expose patient information, the regulatory burden is substantial. Lauren’s background taught him that by default, most internal company data should be accessible. Healthcare flipped that assumption entirely.
By default, you don’t have access to anything. The challenge becomes finding the right balance between protecting sensitive clinical trial data while democratizing access to upstream research data that could spark innovation. Not everything requires the same level of restriction, but determining what needs Fort Knox security versus what can be broadly accessible requires sophisticated thinking about data governance.
Laurent’s advice for digital leaders? Master trade-offs. Own them. Communicate them clearly. The ability to navigate competing priorities defines effectiveness in healthcare technology.
Why Humans Are Underrated in the AI Era
Perhaps Laurent’s most contrarian take addresses the existential anxiety surrounding AGI. While acknowledging AI’s transformative power across drug discovery, clinical development, and commercialization, he argues that AGI discussions have become overrated noise.
“If you ask somebody what’s AGI, you’re gonna maybe or 10 people, you’re gonna get 10 different answers.”
Meanwhile, humans remain dramatically underrated. We possess creativity and problem-solving skills that AI systems can’t replicate. We adapt knowledge across domains in ways that optimization algorithms never will.
Laurent’s own experience with AI coding tools illustrates this perfectly. Rather than replacing his judgment, tools like Cursor and Claude have amplified his ability to prototype quickly and show rather than tell. He’s built three working prototypes in three months; not production-ready code, but functional demonstrations that rally teams around possibilities.
Final Thoughts
Looking ahead, Laurent sees the industry’s next evolution in creating comprehensive semantic layers: structured frameworks that represent business logic and domain knowledge in ways both humans and AI systems can reason over. Think of it as the connective tissue between raw data and actionable intelligence.
This vision harks back to his early days at Business Objects in the late 1990s, but applied to healthcare’s unique complexity. With proper data foundations and semantic layers in place, organizations can finally move beyond treating AI as magic and start treating it as infrastructure.
The bottom line? Stop chasing the latest model. Start building the data foundation that will power the next generation of healthcare innovation.
Laurent’s Background
Laurent Bride is a seasoned digital and technology leader with deep expertise in enterprise software, data platforms, and AI-native systems, now applying that experience to the healthcare sector. He currently serves as Chief Digital Officer at Revolution Medicines, where he leads digital strategy at the intersection of cutting-edge science, data, and patient impact. Previously, Laurent built and scaled high-performance product and engineering organizations across B2B enterprise environments, specializing in big data, cloud, API management, and analytics. He also advises Bain Capital Ventures as a CTO Advisory Board member and serves on the board of Wiiisdom, bringing a strong perspective on data governance, compliance, and building trusted platforms at scale.
